• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Life Sciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 68121.0
  • ISIN : INE570L01029
847.85 22 (2.72%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    823.00

  • Today’s High

    855.95

  • Open

    828.00

  • Perv Close

    825.40

  • 52W Low

    636.10

  • 52W High

    943.00

Key Indicators

  • P/E(TTM)

    70.81

  • Mar.Cap (₹Cr.)

    17,238.09

  • Div & Yield %

    0.00

  • Book Value(₹)

    103.78

  • Debt-Equity Ratio

    2.72

  • AGM Date

    03-Sep-2025

  • EPS

    11.65

  • P/E Ratio

    70.81

Financials Ratios

  • Debt-Equity Ratio

    1.00

  • Mar.Cap (₹Cr.)

    17,238.09

  • RONW (%)

    8.89

  • ROCE (%)

    10.46

Score Board

  • Equity (₹ in Cr.)

    20.88

  • BV (₹)

    103.80

  • Sales( ₹ in Cr.)

    1,642.05

  • NP (in Cr.)

    174.82

  • NP Var(%)

    84.0

  • Div%

    0.0

  • CPS (₹)

    14.40

  • EPS (₹)

    8.40

  • Traded Value (₹ in Lakhs)

    17,227.65

  • 52 Week High

    943.00

  • 52 Week Low

    636.10

  • Price BSE

    825.0

  • Price NSE

    825.00

  • Market Capital( in Cr.)

    17,227.65

  • P/C Ratio

    57.30

  • P/E Ratio

    98.60

  • Price Vs.BV

    8.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,642.05 1,418.68 1,157.40 841.02 751.47 725.36
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,642.05 1,418.68 1,157.40 841.02 751.47 725.36
Other Income 37.34 29.33 27.96 28.15 27.29 17.84
Stock Adjustments -4.13 -23.80 4.59 2.83 16.50 5.51
Total Income 1,675.26 1,424.21 1,189.95 872.00 795.26 748.71
EXPENDITURE :            
Raw Materials 445.52 408.78 413.12 251.14 232.69 207.72
Power and Fuel Cost 48.19 49.49 43.73 31.86 27.25 27.04
Employee Cost 485.56 430.63 353.76 263.37 203.64 202.50
Other Manufacturing Expenses 95.35 84.73 90.06 78.21 50.32 48.82
Selling and Administration Expenses 135.20 117.15 84.16 84.59 85.45 67.36
Miscellaneous Expenses 35.76 16.06 10.29 9.79 4.44 7.57
Employee Benefit Expenses 485.56 430.63 353.76 263.37 203.64 202.50
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,245.57 1,106.84 995.11 718.97 603.79 561.01
Operating Profit 429.69 317.37 194.84 153.03 191.46 187.70
Interest 71.94 81.15 74.38 50.98 32.11 21.26
Gross Profit 357.75 236.22 120.46 102.05 159.35 166.44
Depreciation 126.03 107.21 87.77 79.70 71.77 52.36
Profit Before Tax 231.72 129.01 32.69 22.35 87.58 114.08
Current Tax 33.82 7.97 10.73 9.37 3.73 20.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 24.44 25.81 -2.28 -2.70 18.55 13.47
Reported Net Profit 173.46 95.23 24.24 15.68 65.30 80.14
Extraordinary Items -1.36 0.01 -0.38 11.31 0.00 0.00
Adjusted Net Profit 174.82 95.22 24.62 4.37 65.30 80.14
Adjustment below Net Profit 0.95 1.08 2.39 0.00 0.83 0.74
P & L Balance brought forward 594.05 497.75 478.02 461.76 394.23 315.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 6.90 -0.58 -0.21 1.65
P & L Balance carried down 768.46 594.05 497.75 478.02 460.57 394.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 383.30 396.30 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 38.33 39.63 0.00 0.00
Earnings Per Share-Unit Curr 8.32 53.92 13.76 8.93 36.65 48.92
Earnings Per Share(Adj)-Unit Curr 8.32 - - - - -
Book Value 104.00 572.37 517.79 507.50 486.92 484.05
Book Value(Adj)-Unit Curr 104.00 - - - - -

Shareholding Pattern

  • Promoter Group

    35.15%

  • Public Share Holding

    64.85%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 3,521,560 3,521,560.00 3,521,560 3,521,560
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,521,560 1.69 3,521,560 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,611,290 2.21 4,611,290 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,199,905 5.37 11,199,905 4
Partnership Firms-Indian (Promoter & Group) 53,961,920 25.88 53,961,920 4
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 69,773,115 33.46 69,773,115 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 30,399,524 14.58 30,399,524 98
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,219,995 2.50 5,219,995 5
Mutual Funds / UTI 39,050,215 18.73 39,050,215 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 861,715 0.41 861,715 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 75,531,449 36.22 75,531,449 127
2] Non Institution
Bodies Corporate 632,741 0.30 632,741 113
Clearing Members 27 0.00 27 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,721,405 3.70 7,667,002 905
Foreign Non Institution Other 34,846,957 16.71 34,846,957 2
Hindu Undivided Families 241,418 0.12 241,418 4,147
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,141,290 3.42 7,141,290 9
Individuals holding nominal share capital up to Rs. 1 lakh 6,544,488 3.14 6,539,488 121,059
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,669,352 0.80 1,669,352 3
Others 921,500 0.44 921,500 2
Sub Total 59,719,178 28.64 59,659,775 126,241
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 208,545,302 100.00 208,485,899 126,380

Company Background

Sai Life Sciences LtdPharmaceuticals - Indian - Formulations

  • Sai Life Sciences Ltd
  • BSE Code : 68121.0
  • ISIN : INE570L01029

  • Incorporation Year

    1999

  • Registered Office

    Plot #.DS-7 IKP Knowledge Park
    Turkapally (V) Shameerpet Md, Hyderabad,
    Telangana-500078

  • Telephone

    +91 40 6815 6000

  • FAX

  • Chairman

    Ranga Raju Kanumuri

  • Managing Director

    Krishnamraju Kanumuri

  • Company Secretary

    Runa Karan

  • Auditor

    BSR & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sai Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Life 824.90 1,679.38 1,642.05 70.81 13.87
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10